Scholars Central

CommentaryPublished 9 Jul 2021

Vaccination in the Endemics

Authors: Matteo Brunelli

Department of Pathology and Public Health, University of Verona, Italy

Diagnostic Pathology: Open Access

Volume 6 · Issue 3 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Vaccines give direct protection by making people less susceptible to sickness or infection. Following the publication of genetic sequence of SARS-CoV-2, the virus that causes COVID-19, sparked a surge in global research and development efforts to produce a vaccine to combat the disease. The enormity of the COVID-19 pandemic's humanitarian and economic effect propels the evaluation of next-generation vaccine technology platforms through novel development paradigms. It is imperative to develop various vaccine platforms and strategies in parallel as the immune responses is poorly understood and it is unclear which vaccine strategies will be most successful. A new paradigm for the development of the vaccine was suggested, which includes the development schedule from 10-15 to 1-2 years in order to address the urgent demand.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Diagnostic Pathology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiagnostic Pathology: Open Access
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Matteo Brunelli”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels